Mulay James sold CGON

September 5, 2025 · Form 4 insider transaction

Mulay James sold 12,342 shares of CG Oncology, Inc. at $30.47 per share, a transaction worth $376.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction
Disposed (sell-side)
Shares
12,342
Price
$30.47
Total value
$376.1K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 5, 2025
Filing dateSeptember 8, 2025
Shares owned after14,673
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

View the original Form 4 on SEC EDGAR